Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(0)
•••
Comment by macman1519on Feb 14, 2018 11:06am
79 Views
Post# 27557653

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:TLC-2000: Patent for the neurology market???

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:TLC-2000: Patent for the neurology market???
Chickenman, which is better and why, a pp, ur chance now to tell everyone all the great things a pp provides,  or a jv?????  Here is ur chance to convince us that a pp is the best option!!! Bock, bock, boooooook!!!! Lol, lol, lol!!!!  Ur killin me!!! 
Dont chicken out, man!!! Defend the indefensible!!! We are all eyes!!!!


bionicjoe wrote: Take my advice macman1519 and go with the insanity plea. It's your best chance of the judge being lenient with you. Just looking at the body of your SH posts over the last 6 months will convince any court appointed doctor that they are the actions of an investor who has suffered a major nervous breakdown and thus shouldn't be held accountable for their actions. If it works it would be one more example of you giving the middle finger to the company and getting away with it.


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities